Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析

◆英語タイトル:Aurinia Pharmaceuticals Inc (AUP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15071
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an investigational drug for the treatment of lupus nephritis and focal segmental glomerulosclerosis; and voclosporin ophthalmic solution for dry eye syndrome. It serves the needs of patients and physicians by providing access to therapeutic options and disease awareness. Aurinia Pharmaceuticals works in partnership with patient advocacy groups, healthcare providers and researchers to deliver treatments to people suffering from debilitating diseases. It has operations in Canada and the US. Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia, Canada.

Aurinia Pharmaceuticals Inc Key Recent Developments

Nov 08,2018: Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
Aug 28,2018: Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
Aug 09,2018: Aurinia reports second quarter financial results and operational highlights
May 10,2018: Aurinia Announces 2018 First Quarter Financial Results
Mar 15,2018: Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

This comprehensive SWOT profile of Aurinia Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aurinia Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aurinia Pharmaceuticals Inc – Key Information
Aurinia Pharmaceuticals Inc – Overview
Aurinia Pharmaceuticals Inc – Key Employees
Aurinia Pharmaceuticals Inc – Key Employee Biographies
Aurinia Pharmaceuticals Inc – Key Operational Heads
Aurinia Pharmaceuticals Inc – Major Products and Services
Aurinia Pharmaceuticals Inc – History
Aurinia Pharmaceuticals Inc – Company Statement
Aurinia Pharmaceuticals Inc – Locations And Subsidiaries
Aurinia Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aurinia Pharmaceuticals Inc – Business Description
Aurinia Pharmaceuticals Inc – Corporate Strategy
Aurinia Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Aurinia Pharmaceuticals Inc – Strengths
Aurinia Pharmaceuticals Inc – Weaknesses
Aurinia Pharmaceuticals Inc – Opportunities
Aurinia Pharmaceuticals Inc – Threats
Aurinia Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aurinia Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aurinia Pharmaceuticals Inc, Key Information
Aurinia Pharmaceuticals Inc, Key Ratios
Aurinia Pharmaceuticals Inc, Share Data
Aurinia Pharmaceuticals Inc, Major Products and Services
Aurinia Pharmaceuticals Inc, History
Aurinia Pharmaceuticals Inc, Key Employees
Aurinia Pharmaceuticals Inc, Key Employee Biographies
Aurinia Pharmaceuticals Inc, Key Operational Heads
Aurinia Pharmaceuticals Inc, Other Locations
Aurinia Pharmaceuticals Inc, Subsidiaries
Aurinia Pharmaceuticals Inc, Key Manufacturing facilities
Aurinia Pharmaceuticals Inc, Key Competitors
Aurinia Pharmaceuticals Inc, SWOT Analysis
Aurinia Pharmaceuticals Inc, Ratios based on current share price
Aurinia Pharmaceuticals Inc, Annual Ratios
Aurinia Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Aurinia Pharmaceuticals Inc, Performance Chart
Aurinia Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cardiva Medical Inc:企業の戦略的SWOT分析
    Cardiva Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SeraCare Life Sciences, Inc.-医療機器分野:企業M&A・提携分析
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Adocia SAS (ADOC):企業の財務・戦略的SWOT分析
    Summary Adocia SAS (Adocia) is a biotechnology comapny involved in the develoment of therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. Adocia's novel insulin formulations is used for the treatment of diabetes and BioChaperon …
  • Ezra Holdings Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Ezra Holdings Limited (Ezra Holdings) is an offshore contractor and provider of integrated offshore solutions to the oil and gas industry. The group's service portfolio consists of subsea construction and maintenance, drilling support, towing and mooring, pipe and cable operations, high spee …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Domestic & General Group Holdings Limited:企業の戦略・SWOT・財務情報
    Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nisshinbo Holdings, Inc.:企業の戦略・SWOT・財務分析
    Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rosneft Oil Co (ROSN)-エネルギー分野:企業M&A・提携分析
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • ethris GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ethris GmbH (Ethris) is a biotechnology company that develops and manufactures therapeutics. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vacci …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • 10X Genomics, Inc.:製薬・医療:M&Aディール及び事業提携情報
    Summary 10X Genomics, Inc. (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single cell ATAC sequencer and single cell with barcode technology. It offers single cell gene expression, single cell immune profiling …
  • Inform Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • Billabong International Limited:企業の戦略的SWOT分析
    Billabong International Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Estel Technologies Pvt. Ltd:企業の戦略的SWOT分析
    Estel Technologies Pvt. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CFM International, Inc.:企業の戦略・SWOT・財務情報
    CFM International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CFM International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • First Solar, Inc.:企業の戦略・SWOT・財務情報
    First Solar, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Solar, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Sun-Rype Products Ltd.:企業の戦略・SWOT・財務情報
    Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆